Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
GSI Creos, The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 20% Decrease, Dividend Revised Upward by 5 yen
8101 GSI Creos Corporation 【J-GAAP】
Guidance Update ReportGSI Creos Corporation <8101> [TSE Prime] announced a revision to its performance and dividend after the market closed on March 24th (17:00). The consolidated ordinary profit for the fiscal year ending March 2025 has decreased 22.3%, from the previous forecast of 3.1 billion yen to 2.41 billion yen (compared to 2.99 billion yen in the previous period). This changes the outlook from an anticipated profit increase to a projection of a 19.6% decrease in profit. However, the full-year consolidated net income has been revised upward 5.0%, from the previous forecast of 2.2 billion yen to 2.31 billion yen (compared to 2.01 billion yen in the previous period), increasing the growth rate from 9.0% to 14.4%. The company has further increased its previous forecast of record profits for the first time in four years.
Based on the downwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated ordinary profit has decreased 48.5%, from the previous forecast of 1.42 billion yen to 0.73 billion yen (compared to 1.19 billion yen in the same period of the previous year). This changes the outlook from an anticipated profit increase to a projection of a 38.8% decrease in profit.
At the same time, the company has increased its planned year-end lump-sum dividend for the current fiscal year from the original plan of 90 yen to 95 yen (compared to 83 yen in the previous period).
Kabutan News
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2024 Prev | 70,348 | 1,295 | 1,422 | 963 | 78.5 | 90 | Nov 7, 2024 | J-GAAP |
Oct - Mar, 2024 New | 80,348 | 745 | 732 | 1,073 | 87.4 | 95 | Mar 24, 2025 | J-GAAP |
Revision Rate | +14.2% | -42.5% | -48.5% | +11.4% | +11.4% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 150,000 | 3,100 | 3,100 | 2,200 | 179.3 | 90 | May 15, 2024 | J-GAAP |
Mar, 2025 New | 160,000 | 2,550 | 2,410 | 2,310 | 188.2 | 95 | Mar 24, 2025 | J-GAAP |
Revision Rate | +6.7% | -17.7% | -22.3% | +5.0% | +5.0% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 75,344 | 1,159 | 1,197 | 722 | 58.9 | 83 | May 15, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 80,348 | 745 | 732 | 1,073 | 87.4 | 95 | Mar 24, 2025 | J-GAAP |
YoY | +6.6% | -35.7% | -38.8% | +48.6% | +48.5% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 131,054 | 1,829 | 1,787 | 1,769 | 144.3 | 73 | May 15, 2023 | J-GAAP |
Mar, 2024 | 146,194 | 2,881 | 2,999 | 2,019 | 164.6 | 83 | May 15, 2024 | J-GAAP |
Mar, 2025 Guidance | 160,000 | 2,550 | 2,410 | 2,310 | 188.2 | 95 | Mar 24, 2025 | J-GAAP |
YoY | +9.4% | -11.5% | -19.6% | +14.4% | +14.3% |
Related Articles
Nikkei 225 open on the 25th = 344 yen higher, 37,953 yen
OOMITSU, The Current Fiscal Year Ordinary Profit Revised Downward by 23%
Nikkei 225 close on the 24th = falling for the 3 days in a row, 68 yen lower to 37,608 yen
BrightPath Biotherapeutics, The Current Fiscal Year Net Income Loss Widened in Downward Revision
NITTO KOHKI, The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 5% Decrease, Dividend Revised down by 9 yen
Nakabohtec Corrosion Protecting, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 15% Increase, Highest in Four Terms, Dividend Revised Upward by 75 yen
Abalance, Previously Undecided Dividend for Current Fiscal Year Set at 3 yen
TOMOE ENGINEERING, Dividend Effectively Increased
gremz, Current Fiscal Year Dividend Revised Upward by 18 yen
IKEGAMI TSUSHINKI, The Current Fiscal Year Ordinary Profit Revised Downward by 71%, Dividend Revised down by 23 yen